Altamira Therapeutics Ltd (NASDAQ:CYTO)
| 0.31 Delayed Data As of Dec 01 |  -0.0812 / -20.76%Today’s Change | 0.09 Today|||52-Week Range 6.00 | -93.61% Year-to-Date |
Latest CYTO News | Press Releases
No recent news for Altamira Therapeutics Ltd.
Today’s Trading
| Previous close | 0.39 |
| Today’s open | 0.42 |
| Day’s range | 0.30 - 0.46 |
| Volume | 658,297 |
| Average volume (3 months) | 9,017,099 |
| Market cap | $2.7M |
Data as of 3:59pm ET, 12/01/2023
Growth & Valuation
| Earnings growth (last year) | -6.20% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +357.97% |
| P/E ratio | NM |
| Price/Sales | 13.80 |
| Price/Book | -- |
Financials
| Last reporting date | August 15, 2019 |
| EPS forecast (this quarter) | -$32.00 |
| Annual revenue (last year) | $320.0K |
| Annual profit (last year) | -$27.8M |
| Net profit margin | -8,680.31% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Hamilton, Hamilton |
Forecasts
